S2E48 - Probiotics Mastery: AAD Prevention, Eczema Protection, and the Sepsis Safety Rule

Welcome to Season 2 of AMC Clinical Deep Dive!

Probiotics are a high-yield OSCE topic, from preventing antibiotic-associated diarrhoea (AAD) to reducing infant eczema risk by 80%. This episode explores NHMRC Level 1 evidence for Lactobacillus rhamnosus GG and Saccharomyces boulardii. We break down the optimal dose (5–40 billion CFU/day) and the critical safety red flag: always avoid probiotics in immunocompromised or critically ill patients due to sepsis risks. Master strain-specific prescribing and the "sprinkle" technique for infants to deliver the evidence-based management plan examiners demand!

#AMCClinicalExam #Probiotics #AntibioticAssociatedDiarrhoea #InfantAtopicEczema #OSCE #IMGAustralia #LactobacillusrhamnosusGG #Saccharomycesboulardii

Pro Tip: In the OSCE, safety is your top priority. While probiotics are generally safe, you must explicitly screen the patient for immunocompromised status or severe illness before recommending them. Additionally, when discussing infant use, mention that capsules can be "opened and sprinkled on food" to overcome the low doses found in many commercial infant drops. Demonstrating this practical, safety-first clinical reasoning will show the examiner you are ready for Australian practice!

🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.